Literature DB >> 23224274

Association of autoimmune diseases with lichen sclerosus in 532 male and female patients.

Alexander Kreuter1, Yulia Kryvosheyeva, Sarah Terras, Rose Moritz, Katrin Möllenhoff, Peter Altmeyer, Nina Scola, Thilo Gambichler.   

Abstract

Lichen sclerosus is a relatively common chronic inflammatory skin disease that predominantly affects the anogenital area. Accumulating evidence indicates that lichen sclerosus in women may be associated with other autoimmune disease, whereas this association seems to lack in male patients. We retrospectively evaluated the prevalence of autoimmune diseases and serological parameters indicative for autoimmunity in male and female patients with lichen sclerosus. Of the 532 patients (396 women, 136 men; 500 adults, 32 children; mean age: 49 years; range 1-89 years; female:male ratio 3:1), 452 (85%) had genital and 80 (15%) had extragenital disease. In women, lichen sclerosus was significantly more often associated with at least one autoimmune disease as compared to men (odds ratio [OR] 4.3, 95% confidence interval [CI] 1.9-9.6; p<0.0001). Moreover, female patients with lichen sclerosus had sinificantly more often associated autoimmune thyroid diseases (OR 4.7, 95% CI 1.8-11.9; p<0.0002), antithyroid-antibodies (OR 2.7, 95% CI 1.1-6.5; p=0.023), and elevated autoantibodies (OR 4.1, 95% CI 1.9-9.3; p<0.0001) as compared to male patients. This observation is suggestive for a different pathogenetic background in male and female patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23224274     DOI: 10.2340/00015555-1512

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  19 in total

Review 1.  Lichen Sclerosus-Presentation, Diagnosis and Management.

Authors:  Gudula Kirtschig
Journal:  Dtsch Arztebl Int       Date:  2016-05-13       Impact factor: 5.594

2.  Balanitis xerotica obliterans: An observational, descriptive and retrospective clinical study.

Authors:  Gyula László Fekete; Dominik Schwarzkopf-Kolb; Ilarie Brihan; Daniel Boda; László Fekete
Journal:  Exp Ther Med       Date:  2022-03-31       Impact factor: 2.447

Review 3.  The Immunogenetics of Morphea and Lichen Sclerosus.

Authors:  Pooya Khan Mohammad Beigi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Extragenital lichen sclerosus: a comprehensive review of clinical features and treatment.

Authors:  Aaron Burshtein; Joshua Burshtein; Sergey Rekhtman
Journal:  Arch Dermatol Res       Date:  2022-10-05       Impact factor: 3.033

5.  Comorbidity of Dermal and Cardiovascular Disorders with Lichen Sclerosus: A Case-control Study.

Authors:  Niina Hieta; Marjut Rintala; Jenni M Söderlund; Kurki Samu; Katri Orte; Sakari Hietanen
Journal:  Acta Derm Venereol       Date:  2021-11-17       Impact factor: 3.875

Review 6.  Vulvar pruritus-Causes, Diagnosis and Therapeutic Approach.

Authors:  Linn Woelber; Katharina Prieske; Werner Mendling; Barbara Schmalfeldt; Hans-Jürgen Tietz; Anna Jaeger
Journal:  Dtsch Arztebl Int       Date:  2020-02-21       Impact factor: 5.594

7.  The co-occurrence of lichen sclerosus et atrophicus and celiac disease.

Authors:  Ayse Serap Karadag; Mukaddes Kavala; Emin Ozlu; İlkin Zindancı; Seyma Ozkanlı; Zafer Turkoglu; Ebru Zemheri
Journal:  Indian Dermatol Online J       Date:  2014-12

Review 8.  Male genital lichen sclerosus.

Authors:  Christopher Barry Bunker; Tang Ngee Shim
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

9.  Evaluation of ceftiofur-PHBV microparticles in rats.

Authors:  Cristian Vilos; Luis Constandil; Paula I Rodas; Mario Cantin; Katherine Zepeda; Natalia Herrera; Luis A Velasquez
Journal:  Drug Des Devel Ther       Date:  2014-05-29       Impact factor: 4.162

10.  The presence of human papillomavirus and Epstein-Barr virus in male Chinese lichen sclerosus patients: a single center study.

Authors:  Yumeng Zhang; Qiang Fu; Xiong Zhang
Journal:  Asian J Androl       Date:  2016 Jul-Aug       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.